Company Legal Name
Latest Valuation
Founded Year
Headquarter
XtalPi Inc. develops an integrated software and robotics platform that leverages artificial intelligence to accelerate drug discovery and materials research and development. Founded in 2014 and headquartered in Cambridge, Massachusetts, the company combines quantum physics, AI algorithms, and automated laboratory systems to predict molecular properties and optimize pharmaceutical compounds. XtalPi's platform enables pharmaceutical companies and research institutions to reduce development timelines and costs by providing computational predictions validated through robotic experimentation. The company serves clients across the global pharmaceutical and materials science sectors, positioning itself at the intersection of computational chemistry and laboratory automation to transform traditional R&D workflows.
Revenue & Revenue Growth Share
Revenue
Revenue Growth
Available in most regions; subject to local regulations.
Open to non-accredited investors with KYC/AML compliance. U.S. investors must meet SEC requirements.
$10 per token, enabling fractionalized access to Pre-IPO shares.
Mandatory identity (KYC) and proof of funds checks.
Variable, applied to investment amounts.
Charged on realized profits.
Tokens may be locked for 6–12 months; resale depends on secondary market liquidity.
Prices reflect past funding rounds, not guaranteed future value.
Biotech depends on regulatory approvals; fintech faces evolving digital asset rules.
Blockchain or custodian issues could delay transfers or verification.
Changing laws may affect tradability or taxation.
